+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Nucleic Acid Isolation and Purification Market Size, Share & Industry Trends Analysis Report By Application, By Product, By Method (Magnetic Beads, Column Based, Reagent Based), By Type , By End User, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 182 Pages
  • November 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5917107
The Europe Nucleic Acid Isolation and Purification Market would witness market growth of 8.8% CAGR during the forecast period (2023-2030).

There is an increasing demand for point-of-care testing, driving the development of portable and rapid nucleic acid isolation devices that can be used in decentralized settings such as clinics, remote locations, or even directly at the patient's side. These advancements enable quicker and more immediate diagnostic decisions, particularly in emergency situations or resource-limited environments. Point-of-care nucleic acid extraction devices are instrumental in expediting the diagnostic process and improving patient outcomes.

There is a growing focus on developing specialized extraction kits tailored for specific sample types or applications. These kits are optimized to extract nucleic acids from diverse sources efficiently. Tailored kits enhance the efficiency and accuracy of nucleic acid isolation for specific purposes, whether it's environmental samples, clinical specimens, forensic materials, or agricultural sources. This trend ensures that the extraction process is optimized for varying sample types, leading to higher quality and better outcomes in downstream applications.

Europe is experiencing demographic changes, with a growing proportion of elderly citizens. This demographic shift leads to increased healthcare expenditure due to higher utilization of healthcare services. For example, countries like Germany and Italy have a substantial percentage of their populations aged 65 and older, resulting in higher healthcare costs associated with age-related conditions and long-term care. Therefore, rising investments in healthcare facilities in Europe is expected to drive the growth of the market in the future.

The Germany market dominated the Europe Nucleic Acid Isolation and Purification Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $715.9 million by 2030. The UK market is exhibiting a CAGR of 7.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.6% during (2023 - 2030).

Based on Application, the market is segmented into Diagnostics, Drug Discovery & Development, Agriculture & Animal Research, and Personalized Medicine & Others. Based on Product, the market is segmented into Reagents, Kits, and Instruments. Based on Method, the market is segmented into Magnetic Beads, Column Based, Reagent Based, and Others. Based on Type, the market is segmented into Plasmid DNA Isolation & Purification, Total RNA Isolation & Purification, Circulating Nucleic Acid Isolation & Purification, Genomic DNA Isolation & Purification, Messenger RNA Isolation & Purification, microRNA Isolation & Purification, and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad laboratories, Inc., Illumina, Inc., and New England Biolabs, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application
  • Diagnostics
  • Drug Discovery & Development
  • Agriculture & Animal Research
  • Personalized Medicine & Others
By Product
  • Reagents
  • Kits
  • Instruments
By Method
  • Magnetic Beads
  • Column Based
  • Reagent Based
  • Others
By Type
  • Plasmid DNA Isolation & Purification
  • Total RNA Isolation & Purification
  • Circulating Nucleic Acid Isolation & Purification
  • Genomic DNA Isolation & Purification
  • Messenger RNA Isolation & Purification
  • microRNA Isolation & Purification
  • Others
By End User
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • F.Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Promega Corporation
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Bio-Rad laboratories, Inc.
  • Illumina, Inc.
  • New England Biolabs, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Nucleic Acid Isolation and Purification Market, by Application
1.4.2 Europe Nucleic Acid Isolation and Purification Market, by Product
1.4.3 Europe Nucleic Acid Isolation and Purification Market, by Method
1.4.4 Europe Nucleic Acid Isolation and Purification Market, by Type
1.4.5 Europe Nucleic Acid Isolation and Purification Market, by End User
1.4.6 Europe Nucleic Acid Isolation and Purification Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2022
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar - 2023, Oct) Leading Players
4.5 Porter’s Five Forces Analysis
Chapter 5. Europe Nucleic Acid Isolation and Purification Market by Application
5.1 Europe Diagnostics Market by Country
5.2 Europe Drug Discovery & Development Market by Country
5.3 Europe Agriculture & Animal Research Market by Country
5.4 Europe Personalized Medicine & Others Market by Country
Chapter 6. Europe Nucleic Acid Isolation and Purification Market by Product
6.1 Europe Reagents Market by Country
6.2 Europe Kits Market by Country
6.3 Europe Instruments Market by Country
Chapter 7. Europe Nucleic Acid Isolation and Purification Market by Method
7.1 Europe Magnetic Beads Market by Country
7.2 Europe Column Based Market by Country
7.3 Europe Reagent Based Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Nucleic Acid Isolation and Purification Market by Type
8.1 Europe Plasmid DNA Isolation & Purification Market by Country
8.2 Europe Total RNA Isolation & Purification Market by Country
8.3 Europe Circulating Nucleic Acid Isolation & Purification Market by Country
8.4 Europe Genomic DNA Isolation & Purification Market by Country
8.5 Europe Messenger RNA Isolation & Purification Market by Country
8.6 Europe microRNA Isolation & Purification Market by Country
8.7 Europe Others Market by Country
Chapter 9. Europe Nucleic Acid Isolation and Purification Market by End User
9.1 Europe Hospitals & Diagnostic Centers Market by Country
9.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
9.3 Europe Academic Research Institutes Market by Country
9.4 Europe Contract Research Organizations Market by Country
9.5 Europe Others Market by Country
Chapter 10. Europe Nucleic Acid Isolation and Purification Market by Country
10.1 Germany Nucleic Acid Isolation and Purification Market
10.1.1 Germany Nucleic Acid Isolation and Purification Market by Application
10.1.2 Germany Nucleic Acid Isolation and Purification Market by Product
10.1.3 Germany Nucleic Acid Isolation and Purification Market by Method
10.1.4 Germany Nucleic Acid Isolation and Purification Market by Type
10.1.5 Germany Nucleic Acid Isolation and Purification Market by End User
10.2 UK Nucleic Acid Isolation and Purification Market
10.2.1 UK Nucleic Acid Isolation and Purification Market by Application
10.2.2 UK Nucleic Acid Isolation and Purification Market by Product
10.2.3 UK Nucleic Acid Isolation and Purification Market by Method
10.2.4 UK Nucleic Acid Isolation and Purification Market by Type
10.2.5 UK Nucleic Acid Isolation and Purification Market by End User
10.3 France Nucleic Acid Isolation and Purification Market
10.3.1 France Nucleic Acid Isolation and Purification Market by Application
10.3.2 France Nucleic Acid Isolation and Purification Market by Product
10.3.3 France Nucleic Acid Isolation and Purification Market by Method
10.3.4 France Nucleic Acid Isolation and Purification Market by Type
10.3.5 France Nucleic Acid Isolation and Purification Market by End User
10.4 Russia Nucleic Acid Isolation and Purification Market
10.4.1 Russia Nucleic Acid Isolation and Purification Market by Application
10.4.2 Russia Nucleic Acid Isolation and Purification Market by Product
10.4.3 Russia Nucleic Acid Isolation and Purification Market by Method
10.4.4 Russia Nucleic Acid Isolation and Purification Market by Type
10.4.5 Russia Nucleic Acid Isolation and Purification Market by End User
10.5 Spain Nucleic Acid Isolation and Purification Market
10.5.1 Spain Nucleic Acid Isolation and Purification Market by Application
10.5.2 Spain Nucleic Acid Isolation and Purification Market by Product
10.5.3 Spain Nucleic Acid Isolation and Purification Market by Method
10.5.4 Spain Nucleic Acid Isolation and Purification Market by Type
10.5.5 Spain Nucleic Acid Isolation and Purification Market by End User
10.6 Italy Nucleic Acid Isolation and Purification Market
10.6.1 Italy Nucleic Acid Isolation and Purification Market by Application
10.6.2 Italy Nucleic Acid Isolation and Purification Market by Product
10.6.3 Italy Nucleic Acid Isolation and Purification Market by Method
10.6.4 Italy Nucleic Acid Isolation and Purification Market by Type
10.6.5 Italy Nucleic Acid Isolation and Purification Market by End User
10.7 Rest of Europe Nucleic Acid Isolation and Purification Market
10.7.1 Rest of Europe Nucleic Acid Isolation and Purification Market by Application
10.7.2 Rest of Europe Nucleic Acid Isolation and Purification Market by Product
10.7.3 Rest of Europe Nucleic Acid Isolation and Purification Market by Method
10.7.4 Rest of Europe Nucleic Acid Isolation and Purification Market by Type
10.7.5 Rest of Europe Nucleic Acid Isolation and Purification Market by End User
Chapter 11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.5.2 Product Launches and Product Expansions:
11.1.6 SWOT Analysis
11.2 Qiagen N.V.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Product Launches and Product Expansions:
11.2.5.2 Acquisition and Mergers:
11.2.5.3 Geographical Expansions:
11.2.6 SWOT Analysis
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Partnerships, Collaborations, and Agreements:
11.3.5.2 Product Launches and Product Expansions:
11.3.6 SWOT Analysis
11.4 Merck KGaA
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Promega Corporation
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Partnerships, Collaborations, and Agreements:
11.5.2.2 Product Launches and Product Expansions:
11.5.3 SWOT Analysis
11.6 Agilent Technologies, Inc.
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental and Regional Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Danaher Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 SWOT Analysis
11.8 Bio-Rad laboratories, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Product Launches and Product Expansions:
11.8.5.2 Acquisition and Mergers:
11.8.6 SWOT Analysis
11.9 Illumina, Inc.
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Regional Analysis
11.9.4 Research & Development Expense
11.9.5 SWOT Analysis
11.10. New England Biolabs, Inc.
11.10.1 Company Overview
11.10.2 SWOT Analysis

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Promega Corporation
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Bio-Rad laboratories, Inc.
  • Illumina, Inc.
  • New England Biolabs, Inc.

Methodology

Loading
LOADING...